Lilly's soft tissue sarcoma treatment gets U.S. approval
October 19, 2016 at 14:18 PM EDT
Oct 19 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eli Lilly and Co's treatment for adults with advanced soft tissue sarcoma (STS).